Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women

被引:117
作者
Yaffe, K
Grady, D
Pressman, A
Cummings, S
机构
[1] Univ Calif San Francisco, Vet Adm Med Ctr, Dept Psychiat, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA
[3] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA
[4] San Francisco VA Med Ctr, San Francisco, CA USA
[5] Kaiser Permanente Med Care Program, Oakland, CA USA
关键词
D O I
10.1111/j.1532-5415.1998.tb02713.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVE: To determine the association between serum estrogen levels, cognitive performance, and risk of cognitive decline in older women. DESIGN: Prospective cohort study with an average follow-up of 5 years. SETTING: Clinical centers in Baltimore, MD, Minneapolis, MN, Portland, OR, and the Monongahela Valley in Pennsylvania. PARTICIPANTS: 532 women aged 65 years or older who were the controls from two nested case-control studies in the ongoing Study of Osteoporotic Fractures. OUTCOME MEASURES:Three cognitive tests - a modified Mini-Mental Status Exam, Digit Symbol, and Trails B - were administered at study initiation and were then repeated approximately 5 years later. Estrone and estradiol levels were determined by radioimmunoassay at two laboratories from baseline stored serum. RESULTS: The characteristics of the women in the four serum estrogen quartiles did not differ except that body weight and change in weight since age 50 increased directly with higher quartile of serum estrogen (P < .001, for both estrone and estradiol). Initial cognitive performance on all three tests did not differ consistently by quartile of estradiol or by the estradiol to estrone ratio. Women in the higher estrone quartiles had 15% lower (worse) scores on Digit Symbol compared with the lower quartiles (P = .004) but there was no difference by quartile on the modified MMSE or on Trails B. Cognitive function test scores declined over the 5 years of follow-up. There was no difference in amount of change by quartile of estradiol, but women in the higher estrone quartiles had greater reduction of scores on Trails B compared with those in the lower quartiles (P = .012), even after adjusting for age, education, depression, stroke history, weight, and change in weight since age 50. The age-adjusted odds of cognitive decline (defined as tenth percentile of women with the largest decline in cognitive performance) did not vary across quartile of estrone or estradiol. CONCLUSIONS: Endogenous estrogens are not associated consistently with cognitive performance or risk of cognitive decline on a selected battery of cognitive tests in older community-dwelling women. Worse performance on two cognitive tests among women with higher estrone levels was surprising and warrants further investigation.
引用
收藏
页码:816 / 821
页数:6
相关论文
共 41 条
[1]  
APPLEBAUMBOWDEN D, 1989, J LIPID RES, V30, P1895
[2]   ESTROGEN REPLACEMENT THERAPY AND COGNITIVE FUNCTION IN OLDER WOMEN [J].
BARRETTCONNOR, E ;
KRITZSILVERSTEIN, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (20) :2637-2641
[3]  
CAMPBELL S, 1977, CLIN OBSTET GYNAECOL, V4, P31
[4]   PREVALENCE AND DETERMINANTS OF ESTROGEN REPLACEMENT THERAPY IN ELDERLY WOMEN [J].
CAULEY, JA ;
CUMMINGS, SR ;
BLACK, DM ;
MASCIOLI, SR ;
SEELEY, DG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) :1438-1444
[5]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[6]   TOTAL AND FREE ESTROGENS AND ANDROGENS IN POST-MENOPAUSAL WOMEN WITH HIP-FRACTURES [J].
DAVIDSON, BJ ;
ROSS, RK ;
PAGANINIHILL, A ;
HAMMOND, GD ;
SIITERI, PK ;
JUDD, HL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (01) :115-120
[7]  
DITKOFF EC, 1991, OBSTET GYNECOL, V78, P991
[8]   Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women [J].
Ettinger, B ;
Bainton, L ;
Upmalis, DH ;
Citron, JT ;
VanGessel, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (01) :112-117
[9]  
Fedor-Freybergh P, 1977, Acta Obstet Gynecol Scand Suppl, V64, P1
[10]  
Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975